Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 55 and 75 years.
- People who have been clinically diagnosed with Idiopathic Parkinson's Disease using a specific standard set of diagnostic guidelines known as the UK Parkinson's Disease Society Brain Bank Criteria.
- People whose Parkinson's disease is at a mild to moderate stage, rated between 1 and 2.5 on the Hoehn & Yahr scale.
- People who score between 23 and 26 on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA), which indicates mild cognitive impairment.
- People who have been on a stable dose of their Parkinson's medications for at least 4 weeks before the screening visit.
- People who have noticed, or whose family or carers have noticed, a decline in memory or thinking that has been ongoing for at least 6 months.
- People who are able to walk on their own, with or without a walking aid such as a cane or walker.
- People who have adequate vision and hearing to take part in the study procedures.
- People who are willing to give written consent to participate and to follow the requirements of the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have other neurological conditions that could affect thinking or memory, such as Alzheimer's disease, stroke, or brain tumours.
- People who have serious psychiatric conditions, such as major depressive disorder or schizophrenia.
- People with a recent history of drug or alcohol abuse.
- People with serious uncontrolled health conditions such as high blood pressure, diabetes, heart disease, or other conditions that could interfere with taking part in the study.
- People who have been diagnosed with Parkinson's Disease Dementia (PDD), which is a more severe form of cognitive impairment linked to Parkinson's disease.
- People with recent head injury, uncontrolled thyroid problems, vitamin B12 deficiency, or other conditions known to affect memory and thinking.
- People who have previously had Deep Brain Stimulation (DBS), which is a surgical treatment involving electrodes placed in the brain.
- People who have taken part in another clinical trial in the last 3 months that could interfere with this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-16677137704
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Montreal Cognitive Assessment (MoCA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.